Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Bristol Myers ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to ...

Bristol Myers Squibb (BMY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

As management tackles key issues head-on, Bristol Myers Squibb stock offers a steady 4% yield, with further upside potential.

Bristol Myers Squibb's aggressive M&A and in-house R&D efforts have driven the portfolio renewal cadence and ongoing ...

Bristol Myers Squibb's growth portfolio now drives nearly 60% of revenue, offsetting legacy drug declines and supporting total revenue growth. See why BMY stock is a Buy.

Bristol Myers Squibb (BMY) closed the most recent trading day at $62.84, moving 1.19% from the previous trading session.

According to same-day coverage of market data, Bristol Myers Squibb stock traded between an intraday low of $66.19 and a high of $67.39 on August 30, 2026, before closing at $66.47, placing the close ...

Bristol Myers Squibb is facing down a major patent cliff, which is a problem and a huge motivating force.